The World Health Organization (WHO) has developed a case definition for the surveillance of severe acute respiratory infection (SARI) that was to be used for influenza surveillance to monitor its trends over time and compare data from different countries and regions. In July 2012, the WHO defined SARI as "an acute respiratory illness with a history of fever or measured fever of ≥38°C and cough, with onset within the last 7 days, requiring hospitalization" and recommended its use in all age groups [1] . In January 2014, to improve its sensitivity, this definition was modified to expand to 10 days, the interval since symptom onset, on the basis that a substantial proportion of influenza viruses can be detected among the SARI cases with late sample collection [1] . Although the new SARI case definition has been implemented in some countries such as New Zealand [2] , its performance by age group (children <5 years and older patients) was evaluated in only 1 study in a rural community of India [3] .
Other respiratory viruses (ORVs) cocirculate with influenza viruses and are significant contributors to respiratory illness, especially in children [4] . Although some clinical symptoms may be suggestive of influenza, it has been shown that influenza cannot be distinguished clinically from ORVs [4] . We assessed the performance of the new SARI definition in identifying influenza-or ORV-infected patients by applying it to a population of patients hospitalized with acute respiratory symptoms during the peak weeks of 2 influenza seasons in the province of Quebec, Canada.
METHODS
In the province of Quebec, Canada, a prospective study with virologic assessment for influenza and ORVs was conducted during the peak weeks of influenza circulation among patients admitted for acute respiratory symptoms to 4 acute-care hospitals since 2011-2012. Peak weeks are defined as consecutive weeks with ≥15% of weekly specimens testing positive for influenza as monitored by the provincial sentinel laboratory network. All patients hospitalized for fever/feverishness or cough or sore throat had a nasal specimen collected with a flocked swab. Specimens were tested by the Luminex RVP FAST multiplex, a polymerase chain reaction (PCR) assay that can detect 17 respiratory viruses [5] . Patients admitted for ≥24 hours were invited to participate in the study; those who gave their informed consent were included. Demographic and clinical information of patients were collected using a standardized questionnaire. Additional details are presented elsewhere [5] The PCR results were taken as the "gold standard" in evaluating the performance of the new WHO SARI case definition. As traditionally used in the evaluation of WHO case definitions, the SARI definition performance results were stratified by 2 age groups: children <5 years and patients ≥5 years. New SARI definition's sensitivity, specificity, positive predictive value (PPV), and negative predictive value were calculated. Proportions were compared with the χ 2 test or the Fisher's exact test where appropriated. A P value <.05 was considered statistically significant.
RESULTS

Patient Characteristics
During the 2012-2013 and the 2014-2015 influenza seasons' peaks, 2025 patients were swabbed. After the exclusion of those who refused to participate or were unable to participate, healthcare-acquired infections, and lost specimens, 1258 cases were included in the analysis. The distribution by age group and proportions of detected influenza and ORVs were similar between swabbed nonparticipants and study participants [5] . Among the 1258 patients included in the analysis, 243 (19%) were children <5 years. Overall, influenza A(H3N2) was the predominating strain (96% in 2012-2013 and 94% in 2014-2015) and influenza B was uncommon (1% in 2012-2013 and 3% in 2014-2015). Characteristics of influenza-positive and influenza-negative patients by age strata are presented in Table 1 . Influenza and ORVs were detected in 20% and 71%, respectively, of the children <5 years (71% of ORVs were respiratory syncytial virus [RSV]) compared with 52% and 14% in older patients. The 2014 SARI case definition was met by 56% (n = 701) of patients (56% in 2012-2013 and 55% in 2014-2015), with a higher proportion in children <5 years (73%) than in older patients (52%, P < .001) ( Table 1) . The proportion of patients meeting the SARI case definition was not significantly different between influenza-positive and influenza-negative children <5 years ( Table 1 ).
The New Severe Acute Respiratory Infection Case Definition Performance
The sensitivity of the SARI case definition to detect influenza was comparable between children aged <5 years and older patients (65% vs 57%, P = 0.28) ( Table 2) , whereas its specificity and PPV were 2-to 3-fold lower in younger patients than in older patients (specificity 25% versus 55%; PPV 18% versus 58%, P < .0001 for both comparisons). In <5-year-olds, the sensitivity of the SARI case definition to detect ORV (79%) was higher than to detect influenza (65%) (P = .06). The PPV of the SARI case definition to detect ORVs was 5 times higher in <5-year-olds (76%) than in older patients (13%) (P < .0001). No significant differences in the SARI definition sensitivity, specificity, and predictive performance were detected by age strata in children aged <5 years or in older patients ( Table 2 ). The performance of SARI case definition was similar in the analysis stratified by influenza season (data not presented).
DISCUSSION
Our study shows that during the peaks of the 2012-13 and 2014-2015 influenza seasons, the 2014 WHO SARI case definition was able to correctly identify patients with PCR-confirmed influenza in approximately 60% of both <5-year-old children and older patients hospitalized with respiratory symptoms. However, there were significant differences in the PPV by age and by type of virus. Because disease prevalence affects the predictive value, the lower PPV for influenza (18%) than for ORV (76%) in <5-year-old children is related to a higher proportion of them being hospitalized for ORVs (mostly RSV) than for influenza, even at the peak of the influenza season when the circulation of influenza is the highest. In our study, the best balance of sensitivity and sensitivity of the SARI case definition in young children was detected in those with ORV. The clinical definition for influenza surveillance should be evaluated according to the objective for which it was designed (ie, identifying outbreaks, monitoring seasonal trends, diagnostic or treatment purpose, estimating burden of disease attributable to influenza …). The relative relevance of parameters (ie, sensitivity, specificity, PPV, or likelihood ratio) used to evaluate case definitions depend on which of these surveillance objectives is the priority. As with every case definition, there is a balance to be accomplished between sensitivity and specificity. A more sensitive definition, useful for quantifying influenza-associated disease burden, will detect a larger proportion of influenza cases while testing a large number of patients. A more specific definition, useful for virological surveillance, will be most efficient for detection of influenza cases but will miss a larger proportion of the total influenza cases. Although there is no single "best" balance between sensitivity and specificity of the case definition, the term "best" that we used refers to both the highest value of sensitivity and specificity of case definition. Because circulation of influenza viruses frequently overlaps with circulation of many ORVs, it is relevant to evaluate the performance of the new WHO SARI definition for influenza surveillance in identifying influenza-versus ORV-infected patients. If this new case definition is not intended to capture all influenza cases in young children, it will potentially be useful in resource-limited surveillance systems to monitor trends of influenza-associated disease over time including annual epidemics or future pandemic events, while emphasizing that this case definition does not specifically monitor influenza trends but also other respiratory viral infections.
Previous studies evaluating influenza case definitions among hospitalized patients were mostly limited to adults [6] [7] [8] [9] , with only 3 recent studies including patients of all ages [3, 10, 11] . These recent studies suggest the use of a simplified clinical case definition with inclusion of measured or reported fever and the need to take into the account specific influenza surveillance goals for which the case definition has been designed. The validity of the new SARI case definition stratified by age group has been assessed in only 1 study [3] . This study was conducted among hospitalized patients in a rural area of India over 2 years (May 2009-April 2011) using broad enrollment criteria (including exacerbations of chronic illness). The observed sensitivity of the new SARI definition for detection of PCR-confirmed influenza-infected children <5 years in this study (77%; 95% confidence interval [CI], 62%-87%) was similar to our results (65%; 95% CI, 50%-78%) and higher among older patients (80%; 95% CI, 76%-83%) compared with our study (57%; 95% CI, 53%-62%) [3] . The PPV for influenza in <5-year-old children in the Indian study (16%; 95% CI, 11%-22%), calculated during a period when >10% of influenza tests were positive, was comparable to our study (18%; 95% CI, 13%-24%). The PPV for influenza among patients ≥5 years was higher (33%; 95% CI, 31%-36%) than in younger children in the Indian study; however, it was lower than in our study (58%; 95% CI, 53%-62%). The performance of the new SARI case definition for surveillance of influenza in the examined age groups was considered reasonable in the Indian study. Some of the differences with our study might be explained by the fact that the study in India included the 2009 influenza pandemic (predominantly affecting younger patients), whereas our study was conducted during seasons with influenza A(H3N2) predominance (affecting mostly older patients) and by different demographics of Indian versus Canadian population. The present work has some limitations. First, it was conducted during the peak of influenza seasons dominated by influenza A(H3N2) strain; its results might not be generalizable to the rest of the season or to other seasons with other types/ subtypes of circulating influenza viruses. Second, it included only patients hospitalized with fever/feverishness or respiratory symptoms, and some influenza cases presenting other clinical signs than respiratory symptoms could have been missed. Third, the multiplex assay used in our study has been tested at a Provincial Laboratory of Public Health, and, when compared with a real-time PCR, it had a sensitivity ≥95% for influenza (98% for influenza A virus) [12] ; therefore, some patients may have been misclassified as influenza-negative. However, we do not think this small proportion has impacted the conclusions of our study. Our findings need to be confirmed by applying the SARI case definition to hospital admissions with suspected acute respiratory infections, throughout the entire winter season, and over several years.
CONCLUSIONS
In conclusion, we found that during the peaks of 2 influenza seasons dominated by the A(H3N2) influenza, the new SARI case definition had a reasonable sensitivity in <5-and ≥5-year-old patients. However, it lacked specificity and accurately detected more ORVs than influenza in <5-year-old children. The use of the WHO SARI definition for influenza surveillance in young children should be interpreted with caution according to the specific surveillance goals.
